ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Immunological Methods to Study Monoclonal Antibody Activity in Chronic Lymphocytic Leukaemia
Methods in Molecular Biology - Chronic Lymphocytic Leukemia
◽
10.1007/978-1-4939-8876-1_14
◽
2018
◽
pp. 173-184
◽
Cited By ~ 1
Author(s):
M. J. Carter
◽
L. N. Dahal
◽
K. L. S. Cleary
◽
M. J. E. Marshall
◽
R. R. French
◽
...
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
Lymphocytic Leukaemia
◽
Immunological Methods
◽
Antibody Activity
Start Chat
Download Full-text
Related Documents
Cited By
References
Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16
British Journal of Haematology
◽
10.1111/j.1365-2141.2007.06974.x
◽
2008
◽
Vol 140
(6)
◽
pp. 635-643
◽
Cited By ~ 82
Author(s):
Christophe de Romeuf
◽
Charles-Antoine Dutertre
◽
Magali Le Garff-Tavernier
◽
Nathalie Fournier
◽
Christine Gaucher
◽
...
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
Lymphocytic Leukaemia
◽
Anti Cd20
Start Chat
Download Full-text
Faculty Opinions recommendation of A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727328356.793538169
◽
2017
◽
Author(s):
Varsha Gandhi
◽
Prithviraj Bose
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
B Cell
◽
Hodgkin Lymphoma
◽
Lymphocytic Leukaemia
◽
Phase 1
◽
Non Hodgkin Lymphoma
◽
Anti Cd20
Start Chat
Download Full-text
Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia
British Journal of Haematology
◽
10.1111/j.1365-2141.2006.06324.x
◽
2006
◽
Vol 135
(4)
◽
pp. 475-485
◽
Cited By ~ 17
Author(s):
Mohammad Reza Rezvany
◽
Mahmood Jeddi Tehrani
◽
Claes Karlsson
◽
Jeanette Lundin
◽
Hodjattallah Rabbani
◽
...
Keyword(s):
Monoclonal Antibody
◽
T Cell
◽
Chronic Lymphocytic Leukaemia
◽
B Cell
◽
Lymphocytic Leukaemia
◽
T Cell Repertoire
◽
Cell Repertoire
◽
Cell Chronic Lymphocytic Leukaemia
Start Chat
Download Full-text
Orphan designation: Recombinant chimeric monoclonal antibody against CD20, Treatment of chronic lymphocytic leukaemia
Case Medical Research
◽
10.31525/cmr-17cd5cc
◽
2019
◽
Author(s):
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
Lymphocytic Leukaemia
◽
Orphan Designation
◽
Chimeric Monoclonal Antibody
Start Chat
Download Full-text
Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia
Acta Dermato Venereologica
◽
10.2340/00015555-0762
◽
2010
◽
Vol 90
(1)
◽
pp. 99-100
◽
Cited By ~ 4
Author(s):
N Kluger
◽
G Cartron
◽
D Bessis
◽
B Guillot
◽
C Girard
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
B Cell
◽
Lymphocytic Leukaemia
◽
Cell Chronic Lymphocytic Leukaemia
◽
Anti Cd20
Start Chat
Download Full-text
Ofatumumab,* a novel antiCD20 monoclonal antibody, is active in patients with relapsed or refractory B-cell chronic lymphocytic leukaemia
Inpharma Weekly
◽
10.2165/00128413-200816250-00027
◽
2008
◽
Vol &NA;
(1625)
◽
pp. 12
Author(s):
&NA;
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
B Cell
◽
Lymphocytic Leukaemia
◽
Cell Chronic Lymphocytic Leukaemia
Start Chat
Download Full-text
Anti-CD20 monoclonal antibody [HuMax-CD20]* has produced promising interim results in a phase I/II study of patients with chronic lymphocytic leukaemia
Inpharma Weekly
◽
10.2165/00128413-200515060-00023
◽
2005
◽
Vol &NA;
(1506)
◽
pp. 9
Author(s):
&NA;
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Chronic Lymphocytic Leukaemia
◽
Lymphocytic Leukaemia
◽
Anti Cd20
Start Chat
Download Full-text
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia
Leukemia
◽
10.1038/sj.leu.2403258
◽
2004
◽
Vol 18
(3)
◽
pp. 484-490
◽
Cited By ~ 86
Author(s):
J Lundin
◽
A Porwit-MacDonald
◽
E D Rossmann
◽
C Karlsson
◽
P Edman
◽
...
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
B Cell
◽
Immune Reconstitution
◽
Lymphocytic Leukaemia
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Cell Chronic Lymphocytic Leukaemia
◽
Cellular Immune
Start Chat
Download Full-text
TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA WITH THE HUMANISED CD52 MONOCLONAL ANTIBODY CAMPATH-1H
Journal of Immunotherapy
◽
10.1097/00002371-199508000-00042
◽
1995
◽
Vol 18
(2)
◽
pp. 136
Author(s):
A. Österborg
◽
A. Fassas
◽
M. J.S. Dyer
◽
A. Anagnostopoulos
◽
G. Pangalis
◽
...
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
Lymphocytic Leukaemia
Start Chat
Download Full-text
Monoclonal antibody therapy of chronic lymphocytic leukaemia
Best Practice & Research Clinical Haematology
◽
10.1016/j.beha.2010.01.006
◽
2010
◽
Vol 23
(1)
◽
pp. 133-143
◽
Cited By ~ 15
Author(s):
Bruce D. Cheson
Keyword(s):
Monoclonal Antibody
◽
Chronic Lymphocytic Leukaemia
◽
Lymphocytic Leukaemia
◽
Antibody Therapy
◽
Monoclonal Antibody Therapy
Start Chat
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close